Welcome to LookChem.com Sign In|Join Free

CAS

  • or

215460-39-2

215460-39-2

Post Buying Request

215460-39-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

215460-39-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 215460-39-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,5,4,6 and 0 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 215460-39:
(8*2)+(7*1)+(6*5)+(5*4)+(4*6)+(3*0)+(2*3)+(1*9)=112
112 % 10 = 2
So 215460-39-2 is a valid CAS Registry Number.

215460-39-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-fluoro-4-(4-fluorophenoxy)benzaldehyde

1.2 Other means of identification

Product number -
Other names 3-Fluoro-4-(4-fluorophenoxy)benzaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:215460-39-2 SDS

215460-39-2Relevant articles and documents

BICYCLIC PYRIMIDONE COMPOUNDS

-

Paragraph 0177; 0390, (2014/07/08)

The present invention relates to novel bicyclic pyrimidone compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.

COMPOUNDS

-

Paragraph 0176-0178; 0390-0392, (2013/03/26)

The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 215460-39-2